Back to home

Sample competitive intelligence reports: Tovrelin vs Ossorian

See what KeystoneIQ delivers.

Six example artifacts on one company pair, so you can read them as one workflow: what changed, what it means for open deals, what to say, what to tell the board. Key claims link to their source; on Growth and Pro, briefs also get multi-model verification.

Try this on your competitors. Start free.No credit card required · No annual contract

What lands in your inbox every week, with sources on the key claims.

12 claims 3 corroborated

Competitive Brief: Tovrelin

Last refreshed: Nov 3, 2026 · 8 data sourcesWeeklyVerified IntelligenceVerifiedSample brief

What changed this cycle

  • Ossorian cut mid-market pricing 22%, from $1,200 to $936 a month
  • Ossorian closed a $45M Series B led by Glimmerstone Capital
  • Ossorian shipped Quick Connect onboarding, real-time dashboards and a Slack integration
  • Ossorian now shows up in 3 of 5 competitive deals, up from 1 of 5
  • Fallowmere Analytics added a free tier for teams of up to 5 seats

Predicted Competitor Moves

Growth and Pro
Ossorian
30-60 dayshigh

Launches an Enterprise tier with a dedicated AE motion.

The Series B and a VP Product who ran Varnloft's mid-market line point to an up-market push.

Ossorian
next quartermedium

Adds 10-15 native connectors to narrow the gap with Tovrelin's 50+.

Integrations have shipped at a faster pace on its changelog since the hire.

12 claims verified10 high2 medium
View per-claim sources →

This brief updated 2 battlecards

OssorianFallowmere Analytics
Reading
View as

Executive Summary

High confidenceSources: Tovrelin fact sheet (uploaded doc), h…

Situation: Tovrelin holds a strong position in mid-market analytics with 340+ accounts and an NPS of 62. Until this quarter, Ossorian appeared in 1 of 5 competitive deals.

Complication: Ossorian closed a $45M Series B last week , cut mid-market pricing by 22% and hired a VP Product from Varnloft (background, Sep 22, 2026) . It now appears in 3 of 5 competitive deals , and its G2 rating rose from 4.1 to 4.4 over the last 90 days.

Resolution: Reframe the conversation from price to total cost of ownership and integration depth. Lead with 50+ native connectors vs Ossorian's 18 and a 3-day vs 14-day implementation . Do not match the price cut.

Threat Assessment

Ossorian67▲+26Fallowmere Analytics38▲+3Glenquarrow Insights22▼-3

Ossorian: Threat score: HIGH (67/100). Why: a $45M Series B , a 22% mid-market price cut , a new VP Product and a G2 rating up from 4.1 to 4.4 . It now shows up in 3 of 5 competitive deals, up from 1 of 5. Trigger: an Enterprise tier or a second price cut would push this higher.

Fallowmere Analytics: Threat score: MEDIUM (38/100). Why: a new free tier for teams of up to 5 seats , aimed at smaller teams than Tovrelin's core buyer. Monitor closely. Trigger: a paid mid-market plan.

Glenquarrow Insights: Threat score: LOW (22/100). Why: no product news in over 60 days, so this score reflects general activity. Monitor quarterly. Trigger: a new release or a pricing change.

Deal-Ready Intel

High confidence

Competitive facts structured for every sales conversation

Ossorian

Fact
Ossorian closed a $45M Series B and cut its mid-market tier 22%, from $1,200 to $936 a month.
Impact
Procurement is anchoring on the new price. Calvenmoor Health ($124K) and Dunmarrow Financial ($88K) both paused for a “competitive pricing review” within 10 days of the Series B. Ossorian came up in 3 of your last 4 Gong calls.
Act
Say: “Compare the full 12 months, not the sticker. Ossorian's 14-day implementation costs about $30,800 more in analyst time than our 3-day median, at $2,800 a day.”
Show
The TCO one-pager and the Orrinthal reference: live in 2 days, $41K saved in Year 1 vs its Ossorian quote.

Battlecard Updates

View battlecardHigh confidence

Pricing

Fact: Ossorian cut its mid-market tier from $1,200 to $936 a month. Impact: Buyers comparing mid-market plans see a 22% lower sticker. Act: Lead with the 12-month TCO and the Orrinthal reference.

Product

Fact: Ossorian shipped Quick Connect onboarding, real-time dashboards and a Slack integration. Impact: “Easier to set up” is no longer a clear Tovrelin advantage. Act: Lead with 50+ native connectors vs 18 and multi-source views.

Company

Fact: Ossorian closed a $45M Series B and hired a VP Product from Varnloft (background, Sep 22, 2026). Impact: Expect faster releases and an up-market push. Act: Add both to the company section of the battlecard.

Sources(13 lines)
Claim confidence:10 high confidence2 medium confidence
  • ✓Tovrelin has 340+ accounts, an NPS of 62 and 50+ native connectors.Tovrelin fact sheet (uploaded doc)
  • ~Orrinthal went live in 2 days and saved $41K in Year 1 vs its Ossorian quote.Orrinthal case study (uploaded doc)
  • ✓Calvenmoor Health ($124K) and Dunmarrow Financial ($88K) paused for a competitive pricing review.HubSpot deal notes, Calvenmoor Health and Dunmarrow Finan…
  • ✓Ossorian came up in 3 of the last 4 Gong calls, on pricing and onboarding speed.Gong calls (3 of last 4)
Raw source list
  • Tovrelin fact sheet (uploaded doc)
  • Ossorian closes $45M Series B led by Glimmerstone Capital (news.example.com)
  • Ossorian Form D filing (filings.example.com)
  • Ossorian names a VP Product from Varnloft (news.example.com)
  • Ossorian pricing page (ossorian.example.com/pricing)
  • Ossorian changelog (ossorian.example.com/changelog)
  • Ossorian integrations page (ossorian.example.com/integrations)
  • G2, Ossorian product page (g2.example.com)
  • Fallowmere Analytics pricing page (fallowmere.example.com/pricing)
  • Glenquarrow Insights pricing page (glenquarrow.example.com/pricing)
  • Orrinthal case study (uploaded doc)
  • HubSpot deal notes, Calvenmoor Health and Dunmarrow Financial
  • Gong calls, 3 of the last 4 mention Ossorian

What we checked

  • Tracked 3 competitors.
  • Checked competitor pricing and changelog pages 42 times across 7 days.
  • 4 page changes found: 3 sent to you, 1 held back (Glenquarrow Insights: cosmetic change only).
  • Found 57 items: used 9, kept 10 for context, set aside 38 as off-topic or noise.
  • Nothing new this period from: Glenquarrow Insights.
  • Followed your 3 rules. Fixed 1 line (Compete on price).
Show what changed

  • Offer Calvenmoor Health and Dunmarrow Financial a first-year discount to match Ossorian's price cut.

    Send the TCO one-pager to procurement at Calvenmoor Health and Dunmarrow Financial.

    Rule: Compete on price

  • SentOssorian pricing: mid-market tier dropped from $1,200 to $936 a month.
  • SentOssorian changelog: Quick Connect onboarding, real-time dashboards and a Slack integration.
  • SentFallowmere Analytics pricing: new free tier for teams of up to 5 seats.
  • Held backGlenquarrow Insights pricing page: footer and cookie banner text changed. · cosmetic change only

In the product, the page and signal lines come with weekly briefs. The rules line shows on weekly, quick, deal and deep research briefs once your team has set at least one rule, in the app and in the brief email. Shared links don't include it.

More in the full brief

A full brief also has Competitive Movements, Market Positioning, Objection Handlers, Strategic Implications, a coverage score, a data quality table and a feedback row. Click any citation chip to see the source text, when it was seen and how many sources agree. See the full sample brief →

Try this on your actual competitors.

14 days of Growth features. No credit card. No annual contract. Cancel any time, in app.

Start free, no credit cardSee pricing